John S. Lazo - Search Results

Year	Number of Results
2002	8
2003	10
2004	8
2005	13
2006	6
2007	19
2008	14
2009	20
2010	19
2011	11
2012	6
2013	7
2014	6
2015	4
2016	5
2017	4
2018	7
2019	6
2020	4
2021	4
2022	2
2023	4
2024	1

1

Small molecule targeting of PTPs in cancer.

Lazo JS, McQueeney KE, Burnett JC, Wipf P, Sharlow ER. Lazo JS, et al. Int J Biochem Cell Biol. 2018 Mar;96:171-181. doi: 10.1016/j.biocel.2017.09.011. Epub 2017 Sep 21. Int J Biochem Cell Biol. 2018. PMID: 28943273 Review.

2

Drugging Undruggable Molecular Cancer Targets.

Lazo JS, Sharlow ER. Lazo JS, et al. Annu Rev Pharmacol Toxicol. 2016;56:23-40. doi: 10.1146/annurev-pharmtox-010715-103440. Epub 2015 Nov 2. Annu Rev Pharmacol Toxicol. 2016. PMID: 26527069 Review.

3

The hubris and humility of cancer pharmacology in the post immuno-oncology era.

Lazo JS. Lazo JS. Pharmacol Res Perspect. 2019 Oct 8;7(6):e00527. doi: 10.1002/prp2.527. eCollection 2019 Dec. Pharmacol Res Perspect. 2019. PMID: 31624635 Free PMC article. Review.

4

Is Cdc25 a druggable target?

Lazo JS, Wipf P. Lazo JS, et al. Anticancer Agents Med Chem. 2008 Dec;8(8):837-42. doi: 10.2174/187152008786847738. Anticancer Agents Med Chem. 2008. PMID: 19075566 Free PMC article. Review.

5

Drug discovery algorithm for cutaneous leishmaniasis.

Grogl M, Hickman M, Ellis W, Hudson T, Lazo JS, Sharlow ER, Johnson J, Berman J, Sciotti RJ. Grogl M, et al. Among authors: lazo js. Am J Trop Med Hyg. 2013 Feb;88(2):216-21. doi: 10.4269/ajtmh.11-0812. Am J Trop Med Hyg. 2013. PMID: 23390221 Free PMC article. Review.

6

Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis.

Bloom GS, Lazo JS, Norambuena A. Bloom GS, et al. Among authors: lazo js. Neuropharmacology. 2018 Jul 1;136(Pt B):192-195. doi: 10.1016/j.neuropharm.2017.09.016. Epub 2017 Sep 29. Neuropharmacology. 2018. PMID: 28965829 Free PMC article. Review.

7

An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium.

Lazo JS, Colunga-Biancatelli RML, Solopov PA, Catravas JD. Lazo JS, et al. SLAS Discov. 2023 Sep;28(6):249-254. doi: 10.1016/j.slasd.2023.02.001. Epub 2023 Feb 15. SLAS Discov. 2023. PMID: 36796645 Free PMC article. Review.

8

The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.

Sharlow ER, Koseoglu MM, Bloom GS, Lazo JS. Sharlow ER, et al. Among authors: lazo js. Assay Drug Dev Technol. 2020 Feb/Mar;18(2):97-103. doi: 10.1089/adt.2019.914. Epub 2019 May 16. Assay Drug Dev Technol. 2020. PMID: 31095406 Free PMC article. Review.

9

Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.

Tasker NR, Rastelli EJ, Burnett JC, Sharlow ER, Lazo JS, Wipf P. Tasker NR, et al. Among authors: lazo js. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2008-2015. doi: 10.1016/j.bmcl.2019.06.048. Epub 2019 Jun 27. Bioorg Med Chem Lett. 2019. PMID: 31307888 Review.

10

Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.

Sharlow ER, Wipf P, McQueeney KE, Bakan A, Lazo JS. Sharlow ER, et al. Among authors: lazo js. Expert Opin Investig Drugs. 2014 May;23(5):661-73. doi: 10.1517/13543784.2014.892579. Epub 2014 Mar 13. Expert Opin Investig Drugs. 2014. PMID: 24625356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

169 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year